Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

cbdMD (YCBD) Return on Sales (2016 - 2025)

Historic Return on Sales for cbdMD (YCBD) over the last 10 years, with Q4 2025 value amounting to 0.06%.

  • cbdMD's Return on Sales fell 600.0% to 0.06% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.12%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.11% for FY2025, which is 800.0% up from last year.
  • cbdMD's Return on Sales amounted to 0.06% in Q4 2025, which was down 600.0% from 0.14% recorded in Q3 2025.
  • cbdMD's 5-year Return on Sales high stood at 0.09% for Q2 2024, and its period low was 3.57% during Q2 2022.
  • Its 5-year average for Return on Sales is 0.71%, with a median of 0.2% in 2025.
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by -19400bps in 2021, then skyrocketed by 32900bps in 2023.
  • Over the past 5 years, cbdMD's Return on Sales (Quarter) stood at 1.94% in 2021, then soared by 67bps to 0.63% in 2022, then soared by 71bps to 0.19% in 2023, then skyrocketed by 102bps to 0.0% in 2024, then plummeted by -2012bps to 0.06% in 2025.
  • Its Return on Sales was 0.06% in Q4 2025, compared to 0.14% in Q3 2025 and 0.19% in Q2 2025.